Search
for
Did you mean Taxanes?
Sort by
Research 30 of 415
- Dermatological adverse events with taxane chemotherapy
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation
- Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- Low-Intensity Ultrasound as a Potential Intervention Strategy to Protect Human Scalp Hair Follicles from Taxane-Induced Toxicity
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- 1400 Low-intensity ultrasound protects human scalp hair follicles from taxane-induced toxicity
- 506 Taxane chemotherapy promotes aging of human hair follicles and their stem cells
- 803 Taxane chemotherapy induces epigenetic changes and premature senescence in human scalp hair follicles
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
- Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
- Use of chemotherapy during human pregnancy
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Mucocutaneous side effects of antineoplastic chemotherapy
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Care for alopecia during chemotherapy of cancer patients
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Drug-induced scarring and permanent alopecia